Prognostic role of left atrial volume in elderly patients with symptomatic stable chronic heart failure: comparison

Bogdan A Popescu1, Andreea C Popescu, Francesco Antonini-Canterin

  • 1Prof. Dr. C. C. Iliescu Institute of Cardiovascular Diseases, Bucharest, Romania. bogdan.a.popescu@gmail.com

Insights

Left atrial volume (LAVi) is the strongest independent predictor of long-term outcomes in patients with chronic heart failure (HF). This finding highlights LAVi

Area of Science:

  • Cardiology
  • Echocardiography
  • Heart Failure Research

Background:

  • Left atrial (LA) volume and B-type natriuretic peptide (BNP) are established predictors of adverse outcomes in heart failure (HF).
  • Assessing prognostic markers in symptomatic but stable chronic HF is crucial for patient management.

Purpose of the Study:

  • To compare the prognostic value of left atrial volume index (LAVi), left ventricular diastolic dysfunction (LVDD), and BNP levels for long-term outcomes in stable chronic HF patients.
  • To identify independent predictors of mortality and HF hospitalization.

Main Methods:

  • Study included 46 patients with symptomatic stable chronic HF (mean age 73 years).
  • Echocardiography assessed LV mass, volumes, ejection fraction, and LAVi.
  • LVDD was graded using Doppler, and plasma BNP levels were measured.

Main Results:

  • During a median follow-up of 20 months, 19 events (8 deaths, 11 HF hospitalizations) occurred.
  • Univariate analysis showed LAVi, LVDD, BNP, LV ejection fraction, LV volumes, and LV mass were significant predictors.
  • Multivariate regression identified LAVi as the sole independent predictor of outcome (HR 1.03 per 1 ml/m(2) increase, P=0.02).

Conclusions:

  • Left atrial volume index (LAVi) is the strongest independent predictor of adverse outcomes in elderly patients with symptomatic stable chronic HF.
  • Despite correlations with LVDD and BNP, LAVi independently predicts prognosis in this population.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...